Dr. John Murray has extensive experience in complex life sciences patent prosecution and opinion work, as well as due diligence. John conducts prosecution both domestically and internationally for a wide range of clients, including start-ups and academic clients, as well as larger corporations. He has substantial experience in patent prosecution in life sciences, in areas such as biotechnology, chemistry/organic chemistry, medical devices, molecular biology and biologics (including CRISPR-mediated RNA targeting and viral vector production, recombinant vaccines for immunotherapy, anti-tumor antibodies, viral gene therapy, aptamer mediated delivery, etc) and pharmaceuticals. He also has pursued patents in a diverse range of other fields, such as software and acoustic technology.

John has also had significant experience in patent infringement litigation, Hatch-Waxman and ITC 337 litigation, which enables him to bring a critical perspective to patent prosecution work. He has handled inter partes review, including oral argument before the USPTO Patent Trial and Appeal Board, as well as appeal to the Federal Circuit. In addition, John has managed trademark and copyright matters for clients.

John received his PhD in molecular genetics under the supervision of Professor Sir Alec J. Jeffreys from the University of Leicester, England. He completed a Post-Doctoral Fellowship at Columbia University, after finishing a Post-Doctoral Fellowship at Mt. Sinai School of Medicine in New York. His post-doctoral research investigated the structural biology of cell membrane proteins through use of x-ray crystallography.

After graduating Fordham University Law School, John began his law practice at Kenyon & Kenyon in New York, New York.